Want to join the conversation?
$MRK said it continues to work to achieve manufacturing readiness to supply the EU market, with product launches estimated to begin in 4Q16 or 1Q17. The U.S. FDA approved ZEPATIER 50mg/100mg tablets in January 2016 to treat adult patients with chronic HCV genotype 1 or 4 infection, with or without ribavirin (RBV).
Any idea why some investors are happy about the disastrous $UA results??
Wow! GM killed it with earnings today! Did not expect this after $F gave the feeling it will eclipse the Chevy maker completely!
Oil rebound starting to show up in energy stocks. $XOM $CVX
I have a feeling "CLOUDy" days are ahead, with $AMZN leading the pack.
$AAL is giving pay hikes to its employees but investors are sulking.